Chemours Company Expands Board, Appoints New Independent Director
Company Announcements

Chemours Company Expands Board, Appoints New Independent Director

Chemours Company (CC) has shared an announcement.

Livingston “Tony” Satterthwaite has been appointed to The Chemours Company’s Board of Directors, expanding the board to ten members, effective June 12, 2024. Ensuring strong corporate governance, Satterthwaite is one of nine independent members under NYSE standards. With no prior ties to the company’s executives, he will contribute to the Compensation and Leadership Development Committee and the Environmental, Health, and Safety & Operational Performance Committee, receiving standard non-employee director compensation. The company announced this governance enhancement in a press release following the appointment.

See more data about CC stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskChemours Company Enhances Investor Relations with New Presentation
TheFlyChemours price target lowered to $30 from $35 at BMO Capital
TheFlyChemours price target lowered to $22 from $30 at Barclays
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!